China NMPA Product Recall - ARCHITECT i System, Alinity c and Alinity i, ARCHITECT Integrated Clinical Chemistry and Immunoassay Systems, ARCHITECT System, Alinity i
China NMPA product recall for ARCHITECT i System, Alinity c and Alinity i, ARCHITECT Integrated Clinical Chemistry and Immunoassay Systems, ARCHITECT System, Alinity i by Abbott Laboratories published August 23, 2024. Recall level: Level 3 Recall. On August 23, 2024, the National Medical Products Administration (NMPA) reported a voluntary Class I
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for ARCHITECT i System, Alinity c and Alinity i, ARCHITECT Integrated Clinical Chemistry and Immunoassay Systems, ARCHITECT System, Alinity i by Abbott Laboratories published August 23, 2024. Recall level: Level 3 Recall. On August 23, 2024, the National Medical Products Administration (NMPA) reported a voluntary Class I
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Abbott LaboratoriesInspection Date
Unknown Date
Product Type
ID: 93c0c3fc-2c6d-41fd-93cf-1c55e5caecf9
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox